A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression
Clinical trial NCT03044249 · TERMINATED
Trial details
- NCT number
- NCT03044249
- Sponsor
- Mediti Pharma Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-04
- Primary completion
- 2020-01-30
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.